“It was a pleasure working with Mantell Associates, they maintained a positive outlook and found solutions during a complex recruitment. I can highly recommend their services.”

Vice President of Biometrics, Avance Clinical

Avance Clinical is a full-service CRO for biotechs with a proven track-record for delivering clinical excellence in Australia, New Zealand, Asia, North America and Europe. Avance Clinical specialises in delivering top-tier clinical trials that yield globally accepted data.

Avance Clinical has been recognized for the fourth consecutive year by Frost & Sullivan in 2023, being awarded the Best Practices Customer Value Leadership for Biotech’s award, for its continuous exceptional performance.

Avance Clinical offers pre-clinical consultancy services with their experienced ClinicReady team right through to Phase I and beyond clinical services leveraging significant Government incentive rebates of up to 43.5% and rapid start-up regulatory processes that are available in Australia and highly qualified sites and networks within the United States. With experience across more than 120 therapeutic indications, Avance Clinical can deliver world-class, high-quality, internationally accepted data suitable for FDA and EMA review.

Avance Clinical uses state-of-the-art technology and gold-standard systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, Zelta, Veeva and Medrio are just some of Avance Clinical’s technology partners.

Company website – https://www.avancecro.com/ 

​To find out more about Avance Clinical, contact Thomas White on +44 (0)20 3854 7700 or thomas.white@mantellassociates.com.